Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid Malignancies.

Saved in:
Bibliographic Details
Title: Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid Malignancies.
Authors: Merkel EC; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington. Electronic address: emily.merkel@seattlechildrens.org., Gooley T; Fred Hutchinson Cancer Center, Seattle, Washington., Thakar MS; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Furlan SN; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Summers C; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Kirkey DC; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Hadland B; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Burroughs LM; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Carpenter PA; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Petrovic A; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Goshorn R; Sacred Heart Hospital, Spokane Washington., Irwin R; Mary Bridge Children's Hospital, Tacoma Washington., Bleakley M; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Cooper T; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Tarlock K; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Dahlberg A; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2026 Apr; Vol. 32 (4), pp. 474.e1-474.e13. Date of Electronic Publication: 2025 Dec 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6367
DOI:10.1016/j.jtct.2025.12.003